Camiel Boon, MD, PhD, FEBO, explores the mysteries of central serous chorioretinopathy

News
Video

At the EURETINA congress, Prof Boon discussed controversies in treatment, some driven by critical prospective studies

Camiel Boon, MD, PhD, FEBO, is a professor of ophthalmology at Amsterdam University Medical Center and Leiden University, both in the Netherlands. During the 2025 congress of the European Society of Retina Specialists (EURETINA), he presented multiple talks, including explorations of central serous chorioretinopathy (CSC).

"We wanted to broadly cover this mysterious disease," Prof Boon said in an interview. "Some interesting new insights have emerged in terms of the pathophysiology. One of the key ones is actually that the choroid, and hyper-permeability and thickening of the choroid, is a key finding in central serous chorioretinopathy, and probably at the basis of the disease. This is very important because, of course, this might also indicate why certain treatments, such as photomimic therapy, are more successful for this disease." Prof Boon and colleagues presented several imaging findings which indicated specific leakage patterns from ICG angiography, a key imaging modality for cases of CSC.

Prof Boon also described the challenges of differential diagnosis, including atypical cases of CSC, and described the "relatively controversial" nature of CSC treatment. Watch the full video to hear all about his presentation.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.